Myeloma Minute: Myeloma Patients and COVID-19 Risk


| INNOVATION | Latest Research


Are Myeloma Patients Really at a Higher Risk If Infected with COVID-19?

This week, a report about higher risks for cancer patients who become infected with the coronavirus caused alarm in the myeloma community. IMF Chairman Dr. Brian G.M. Durie analyzes the report and finds it not as alarming as it appears. Also, countries around the world offer a roadmap to the new abnormal.


| EDUCATION | Webinar


Register Now for This IMF Patient & Family Webinar

Join the IMF Patient & Family Webinar on Saturday, May 9, 2020, at 1:00 p.m. PT / 2:00 p.m. MT / 3:00 p.m. CT / 4:00 p.m. ET. This two-hour webinar features a panel discussion about the latest treatments for and management of myeloma led by IMF Chairman Dr. Brian G.M. Durie. Panelists include Dr. Joseph Mikhael of the Translational Genomics Research Institute (TGen), Dr. William Bensinger of the Swedish Medical Center, and Joseph Tariman PhD, RN, from the School of Nursing/College of Science and Health at DePaul University.

Register Now Button.png

| INNOVATION | Latest Research


IMWG Member Co-Authors a Study on Early Immune System Changes in the Development of Multiple Myeloma

The IMF’s International Myeloma Working Group (IMWG) Member Dr. Irene Ghobrial has conducted research in collaboration with Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital (MGH) about immune system changes that occur in the early in the development of multiple myeloma. The study reports that “long before multiple myeloma becomes a malignant disease, the collection of immune system cells and signal carriers amid the tumor cells undergoes dramatic shifts, with alterations in both the number and type of immune cells.”


| INSPIRATION | Vacation Getaway


| ACTION | Patient Assistance


And This Too Shall Pass…
Takeda Expands Patient Assistance

Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself sipping a tropical beverage next to a private pool, just minutes from the Hawaiian coastline.

During the COVID-19 pandemic, Takeda has expanded its patient assistance by implementing a Job Loss Provision to help patients who have lost their jobs due to COVID-19, enhancing free drug programs, adding virtual training for nurses, and more.



| INNOVATION | COVID-19 Research


Sanofi and GSK Partner to Develop a Vaccine to Fight COVID-19

Sanofi and GSK “have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. This technology has produced an exact genetic match to proteins found on the surface of the virus, and the DNA sequence encoding this antigen has been combined into the DNA of the baculovirus expression platform, the basis of Sanofi’s licensed recombinant influenza product in the U.S.”


| ACTION | Advocacy Alert


Bipartisan Group of Senators Advocate for Cancer Drug Parity During Pandemic

Senator Smith (D-MN) and Senator Moran (R-KS) led a bipartisan group of their colleagues in sending a letter to Congressional Leadership late last week. The letter highlights the importance of patient access to oral cancer medications during the COVID-19 pandemic and requests that the next coronavirus relief package include the Cancer Drug Parity Act. The bill would improve access to oral drugs and help cancer patients stay home whenever it is medically feasible for them to do so.

We are thankful for the efforts of these Senators. View more about Senator Smith and Senator Moran’s efforts here. To let your Congressional Representatives know of your support for the Cancer Drug Parity Act during the COVID-19 pandemic, click the button below.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Myeloma and Coronavirus
IMF "Living Well with Myeloma"

Apply for a Grant
Brian D. Novis Research Grant
Apply Now

Hawaiian Vacation Raffle
Kailua-Kona, Hawaii

Hatfield Hike
Appalachian Trail

subscribe_button.png     donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Bristol-Myers Squibb, Genentech, GSK, Sanofi-Genzyme, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.